Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients

Míreanna Comhchosúla

• Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial
  le: Jiménez, Juan J, et al.
  Foilsithe: (2011)
• Etomidate and relative adrenal insufficiency in cardiopulmonary bypass surgery: impact on the postoperative hemodynamic status
  le: Lorenzo, L, et al.
  Foilsithe: (2008)
• Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
  le: Brouard, M, et al.
  Foilsithe: (2008)
• Clinical outcome and mortality associated with postoperative low cardiac output after cardiopulmonary bypass: a cohort study
  le: Jimenez, J, et al.
  Foilsithe: (2008)
• Postoperative dose of tranexamic acid decreases postoperative bleeding and inflammatory response associated with cardiopulmonary bypass: a randomized, double-blind study
  le: Brouard, M, et al.
  Foilsithe: (2008)